• No results found

Urothelial Cancer

Autoimmune hemolytic anemia associated with renal urothelial cancer: A case report and literature review

Autoimmune hemolytic anemia associated with renal urothelial cancer: A case report and literature review

... renal urothelial cancer or malignant lymphoma extension with renal ...renal urothelial cancer or renal cell carcinoma, nephroureterectomy was planned as surgical ...

5

Precision oncology in urothelial cancer

Precision oncology in urothelial cancer

... in cancer management to ...of cancer biology has led to profound clinical benefit for patients, and will continue to mould present and future treatment ...of urothelial cancer, the present ...

13

A pilot study of urinary microRNA as a biomarker for urothelial cancer

A pilot study of urinary microRNA as a biomarker for urothelial cancer

... This study was approved by the Queen’s University Research Ethics Board. After receiving patient consent, we collected voided urine samples immediately prior to transurethral resection of bladder tumour from eligible ...

5

Comparison between completely and traditionally retroperitoneoscopic nephroureterectomy for upper tract urothelial cancer

Comparison between completely and traditionally retroperitoneoscopic nephroureterectomy for upper tract urothelial cancer

... Methods: From January 2014 to December 2014, 107 patients with upper tract urothelial cancer (UTUC) underwent CRNU. The kidney was retroperitoneoscopically dissected and the bladder cuff was cut by ...

7

Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer

Molecular targets in urothelial cancer: detection, treatment, and animal models of bladder cancer

... bladder cancer and perhaps circumvent it ...on urothelial cancer cell lines that have mutated p53 and altered expression of p21, p16, and pRb to better understand their roles in bladder ...bladder ...

18

Urothelial Cancer and the Diagnosis of Subsequent Malignancies

Urothelial Cancer and the Diagnosis of Subsequent Malignancies

... BPRU cancer using ICD-10 histopathologic morphology codes and ICD-0-3 topography codes abstracted from pathology ...post-BPRU cancer diagno- sis, while the second analysis, for males, excluded prostate ...

8

Complexity of FGFR signalling in metastatic urothelial cancer

Complexity of FGFR signalling in metastatic urothelial cancer

... of urothelial cancer patients [6, 9], and further work is required to determine the optimal patient selection criteria for defining the sensitive patient ...

8

Review Article Outcomes after radical nephroureterectomy and segmental ureterectomy in urothelial cancer of ureter: a meta-analysis

Review Article Outcomes after radical nephroureterectomy and segmental ureterectomy in urothelial cancer of ureter: a meta-analysis

... for urothelial cancer of the ureter ...(OS), cancer specific survival (CSS), intravesical recurrence free survival (IRFS), recurrence free survival (RFS) and metastasis free survival (MFS) were ...

9

Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China

Prognosis and risk factors of patients with upper urinary tract urothelial carcinoma and postoperative recurrence of bladder cancer in central China

... tract urothelial cancer. The incidence of urothelial carcinoma in smokers is three times greater than that in nonsmokers, probably owing to a mutation in tumor protein p53, chromosomal changes, ...

8

Dasatinib enhances tumor growth in gemcitabine resistant orthotopic bladder cancer xenografts

Dasatinib enhances tumor growth in gemcitabine resistant orthotopic bladder cancer xenografts

... on urothelial cancer cells with acquired resistance to ...of urothelial cancer, in particular not for therapy-refractory cases after first-line chemotherapy with ...

8

Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer

Histologic variants of urothelial bladder cancer and nonurothelial histology in bladder cancer

... testicular cancer, where it is com- monplace to quantify the amount of each histologic sub- type present within the tumour, there is currently no stan- dard reporting methodology with regards to the amount of ...

6

Denosumab: a new option in the treatment of bone metastases from urological cancers

Denosumab: a new option in the treatment of bone metastases from urological cancers

... Decreased SREs were associated with a potential survival benefit in patients with metastatic RCC and bladder cancer in bone metastatic RCC and bladder cancer. Zoledronic acid has the potential to induce ...

9

Urothelial carcinoma: the evolving landscape of immunotherapy for patients with advanced disease

Urothelial carcinoma: the evolving landscape of immunotherapy for patients with advanced disease

... Avelumab is a fully humanized PD-L1 antibody. Conditional approval for the treatment was granted by the FDA in May 2017 for use in advanced urothelial cancer after progression on or after platinum-based ...

10

Prognostic significance of platelet-to-lymphocyte ratio in urothelial carcinoma patients: a meta-analysis

Prognostic significance of platelet-to-lymphocyte ratio in urothelial carcinoma patients: a meta-analysis

... “urothelial cancer”, “bladder cancer”, “blad- der tumor”, “upper urinary tract cancer”, “upper tract urothelial carcinoma”, and ...

9

Original Article High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder

Original Article High expression of Notch ligand Jagged2 is associated with the metastasis and recurrence in urothelial carcinoma of bladder

... breast cancer; however, its expression profile and its prognostic value in urothelial carcinoma of bladder have not been ...bladder urothelial carcinoma and 20 normal epithelial ...bladder ...

11

Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma

Identification and analysis of long non-coding RNA related miRNA sponge regulatory network in bladder urothelial carcinoma

... oral cancer and its low expres- sion was associated with poor survival in a recent study based on TCGA data analysis ...ovarian cancer tis- sues compared to normal ovary tissues and benign ovar- ian cysts ...

19

Preoperative albumin-to-globulin ratio as a significant prognostic indicator in urologic cancers: a meta-analysis

Preoperative albumin-to-globulin ratio as a significant prognostic indicator in urologic cancers: a meta-analysis

... age distribution, survival type, cutoff value of AGR, cutoff selection, treatment method, follow-up time, overall survival (OS), CSS, disease-free survival (DFS), progression-free survival (PFS) and recurrence-free ...

14

Pelvic lymph node dissection in the context of radical cystectomy: a thorough insight into the connection between patient, surgeon, pathologist and treating institution

Pelvic lymph node dissection in the context of radical cystectomy: a thorough insight into the connection between patient, surgeon, pathologist and treating institution

... bladder cancer varies widely in extent, technique employed, and pathological workup of ...Bladder cancer patients undergoing radical cystectomy with extended PLND appear to have better oncologic outcomes ...

8

A phase I/II trial of fixed dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response

A phase I/II trial of fixed dose stereotactic body radiotherapy with sequential or concurrent pembrolizumab in metastatic urothelial carcinoma: evaluation of safety and clinical and immunologic response

... static urothelial carcinoma, with an overall response rate of 15–26% ...metastatic urothelial carcinoma whose disease has worsened dur- ing or following platinum-containing chemotherapy, or within 12 months ...

9

Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer

Spotlight on atezolizumab and its potential in the treatment of advanced urothelial bladder cancer

... assay was performed in formalin-fixed, paraffin-embedded urothelial tissue and based on the percentage of TCs or ICs with PDL1 expression, regardless of intensity. Both tumors and ICs showed membranous and ...

16

Show all 10000 documents...

Related subjects